Alkali Metals Limited (NSE:ALKALI)

Market Cap	1.04B +6.2%
Revenue (ttm)	899.83M +1.9%
Net Income	10.65M
EPS	1.05
Shares Out	n/a
PE Ratio	97.45
Forward PE	n/a
Dividend	1.00 (1.04%)
Ex-Dividend Date	Aug 14, 2026

Volume	55,397
Open	99.96
Previous Close	101.63
Day's Range	96.00 - 99.96
52-Week Range	46.80 - 107.38
Beta	0.77
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 6, 2026

About Alkali Metals

Alkali Metals Limited manufactures and sells chemicals in India and internationally. The company offers API products, including benzocaine, fluconazole, loperamide hydrochloride, losartan potassium, metformin hydrochloride, phenylephrine hydrochloride, and rabeprazole sodium. It also provides pyridine, acetylpyridine, alkyl borate, aminopyridine, bipyridine, bromopyridine, carbazole, chloropyridine, cyanopyridine, cyclic, diethylamino pyridine, ethoxypyridine, fluoropyridine, hydroxypyridine, methoxypyridine, nitropyridine, picolylalcohol, pyri...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 1968
• Employees: 105
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ALKALI

Financial Performance

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 24, 2026

Data Sources Report a data error